Fig. 7From: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancerRelationship between NCAPD2 and immune infiltration in LUAD and LUSC. (A) Association between NCAPD2 and immune cell types. (B) Correlation between NCAPD2 and DCs, CD4+T cells, CAFs in LUAD and LUSC. (C) Correlation between NCAPD2 expression level and immunomodulators. (D) The relationship between NCAPD2 expression level and MHCsBack to article page